Cheng Priscilla S W, Zaccaria Marta, Biffi Giulia
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, CB2 0RE, UK.
Trends Cancer. 2025 Feb;11(2):135-153. doi: 10.1016/j.trecan.2024.11.005. Epub 2024 Dec 13.
Cancer-associated fibroblasts (CAFs) are abundant components of the tumor microenvironment (TME) of most solid malignancies and have emerged as key regulators of cancer progression and therapy response. Although recent technological advances have uncovered substantial CAF molecular heterogeneity at the single-cell level, defining functional roles for most described CAF populations remains challenging. With the aim of bridging CAF molecular and functional heterogeneity, this review focuses on recently identified functional interactions of CAF subtypes with malignant cells, immune cells, and other stromal cells in primary tumors and metastases. Dissecting the heterogeneous functional crosstalk of specific CAF populations with other components is starting to uncover candidate combinatorial strategies for therapeutically targeting the TME and cancer progression.
癌症相关成纤维细胞(CAFs)是大多数实体恶性肿瘤肿瘤微环境(TME)的丰富组成部分,并已成为癌症进展和治疗反应的关键调节因子。尽管最近的技术进步揭示了单细胞水平上CAF的大量分子异质性,但确定大多数已描述的CAF群体的功能作用仍然具有挑战性。为了弥合CAF分子和功能异质性之间的差距,本综述重点关注原发性肿瘤和转移灶中最近确定的CAF亚型与恶性细胞、免疫细胞和其他基质细胞之间的功能相互作用。剖析特定CAF群体与其他成分之间的异质功能串扰,开始揭示针对TME和癌症进展进行治疗靶向的候选联合策略。